Igc Pharma Inc 's ability to collect accounts receivable sequentially worsen to 5.36, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Igc Pharma Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 68 days, from 16 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 461 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2546 to 3023.

What is Receivable Turnover Ratio?
What is Igc Pharma Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IGC Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter	(Mar 31 2025) IV. Quarter
Y / Y Receivable Change	716.09 %	8.82 %	-95.31 %	-6.82 %	210.71 %
Y / Y Revenue Change	-19.7 %	23.35 %	-53.64 %	20.59 %	11.86 %
Receivable Turnover Ratio (TTM)	5.36	23.44	22.57	5.98	5.71
IGC's Total Ranking	# 3023	# 2546	# 2980	# 452	#
Accounts Receivable average collection period days	68	16	16	61	64
Seq. Receivable Change	1818.92 %	8.82 %	-17.07 %	-52.87 %	155.88 %
Seq. Revenue Change	-16.4 %	65.97 %	-41.77 %	-0.61 %	28.4 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 153
Healthcare Sector	# 462
Overall Market	# 3023

Receivable Turnover Ratio Statistics
High	Average	Low
0.45	0.16	0.01
(Sep 30 2015)		(Sep 30 2021)

IGC Company Profile • Back to IGC Efficiency Comparisons • Compare IGC Receivables Turnover Ratio to its Competitors

Financial Statements
Igc Pharma Inc 's Accounts Receivable	$ 1 Millions	Visit IGC's Balance sheet
Igc Pharma Inc 's Sales TTM	$ 1 Millions	Visit IGC's Income Statement
Sources of IGC's Revenues		Visit IGC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IGC's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IGC's Growth Rates	IGC's Roa	IGC's Inventory Turnover Ratio	IGC's Dividend Comparisons
IGC's Profitability Ratios	IGC's Roi	IGC's Asset Turnover Ratio	IGC's Dividend Growth
IGC's Valuation Ratios	IGC's Roe	IGC's Financial Strength Ratios	IGC's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Inspiremd Inc	4.12	$ 10.502 Millions	$ 2.550 Millions
Medinotec Inc	4.07	$ 10.247 Millions	$ 2.519 Millions
Gyre Therapeutics Inc	4.02	$ 119.383 Millions	$ 29.697 Millions
Vaxart Inc	4.02	$ 243.064 Millions	$ 60.514 Millions
Bridgebio Pharma Inc	3.99	$ 713.069 Millions	$ 178.918 Millions
Biomerica Inc	3.97	$ 4.453 Millions	$ 1.121 Millions
Retractable Technologies Inc	3.95	$ 33.488 Millions	$ 8.484 Millions
Teva Pharmaceutical Industries Limited	3.92	$ 14,105.000 Millions	$ 3,601.250 Millions
Immunitybio inc	3.87	$ 165.792 Millions	$ 42.849 Millions
Insight Molecular Diagnostics Inc	3.85	$ 1.670 Millions	$ 0.434 Millions
Vsee Health Inc	3.84	$ 10.759 Millions	$ 2.805 Millions
Tonix Pharmaceuticals Holding Corp	3.83	$ 29.102 Millions	$ 7.594 Millions
Envoy Medical Inc	3.75	$ 0.207 Millions	$ 0.055 Millions
Biomarin Pharmaceutical Inc	3.72	$ 3,406.614 Millions	$ 915.860 Millions
Ani Pharmaceuticals Inc	3.68	$ 978.379 Millions	$ 265.900 Millions
Vivosim Labs Inc	3.64	$ 0.112 Millions	$ 0.031 Millions
Evofem Biosciences Inc	3.61	$ 18.045 Millions	$ 4.993 Millions
Sensus Healthcare Inc	3.55	$ 18.294 Millions	$ 5.159 Millions
Lifeward ltd	3.38	$ 21.822 Millions	$ 6.454 Millions
Axsome Therapeutics Inc	3.27	$ 776.569 Millions	$ 237.373 Millions
Establishment Labs Holdings Inc	3.25	$ 245.105 Millions	$ 75.416 Millions
Elite Pharmaceuticals Inc	3.11	$ 140.130 Millions	$ 45.059 Millions
Docgo Inc	3.10	$ 294.721 Millions	$ 95.023 Millions
Dbv Technologies S a	3.08	$ 5.018 Millions	$ 1.631 Millions
Macrogenics Inc	2.83	$ 167.674 Millions	$ 59.300 Millions
Harrow Inc	2.69	$ 274.724 Millions	$ 102.078 Millions
Electromed Inc	2.64	$ 72.076 Millions	$ 27.317 Millions
Onemednet Corporation	2.61	$ 1.590 Millions	$ 0.609 Millions
Cumberland Pharmaceuticals Inc	2.27	$ 31.269 Millions	$ 13.764 Millions
60 Degrees Pharmaceuticals Inc	2.13	$ 1.111 Millions	$ 0.522 Millions

Date modified: 2026-08-16T08:24:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.